ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

When Science Defies the Soul: Joshua Candamo’s “R4G3: Vein of Mortals” Redefines the Limits of Humanity

What if immortality wasn’t a gift—but a curse coded in your DNA? Joshua Candamo’s R4G3: Vein of Mortals takes readers on a high-stakes journey into the bleeding edge of science, faith, and the human condition. Equal parts biotech thriller and mythic fantasy, the novel explores what happens when a scientific breakthrough becomes something terrifyingly divine.

At the heart of the story lies Project Joy, a secret government experiment obsessed with ending disease and death. For nearly a century, every test subject has failed—until a condemned murderer named Thomas Evers becomes the first to survive. What should have been the dawn of a new era instead unleashes something ancient, a force intertwined with his very blood: the Veins of Galkur, a conduit between science and the supernatural.

As Dr. Charli Stanwick struggles to control what she’s helped create, she finds herself at war with her conscience, her colleagues, and powerful enemies who see Evers not as a man but as a weapon. Between the U.S. military, a shadowy cult called Societas Arcanorum, and a ruthless billionaire chasing godhood, she must face the ultimate question—where does humanity end, and monstrosity begin?

Candamo writes with cinematic precision and philosophical depth, layering cutting-edge biotech with ancient mysticism. The result is a gripping, thought-provoking exploration of creation, control, and consequence. It’s a story where redemption and ruin walk hand in hand—and the price of saving humanity may be its very soul.

With its blend of emotional gravity, pulse-pounding action, and haunting moral tension, R4G3: Vein of Mortals stands as one of the most daring science fantasy novels of the year.

Book Details

Title: R4G3: Vein of Mortals

Author: Joshua Candamo

Genre: Science Fantasy · Thriller · Biotech Fiction

Available: Now on Amazon.


https://www.amazon.com/dp/B0FTXXNLQC 



Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.54
+0.00 (0.00%)
AAPL  274.11
+0.00 (0.00%)
AMD  207.58
+0.00 (0.00%)
BAC  55.33
+0.00 (0.00%)
GOOG  309.32
+0.00 (0.00%)
META  647.51
+0.00 (0.00%)
MSFT  474.82
+0.00 (0.00%)
NVDA  176.29
+0.00 (0.00%)
ORCL  184.92
+0.00 (0.00%)
TSLA  475.31
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.